论文部分内容阅读
目的观察100例比索洛尔治疗慢性心力衰竭患者的疗效。方法选取本院2014年4月至2016年3月收治的200例慢性心力衰竭患者作为本次实验的研究对象,并根据其临床治疗方案的差异,将参与实验的患者分为两个不同的组别,分别将其定义为研究组以及对照组,平均每个小组的患者均为100例,对照组采取常规的方式的进行治疗,研究组则为患者提供比索洛尔进行治疗,对比并分析两个组别的临床疗效。结果通过比较得知,研究组患者的总有效率与对照组患者相比,具有明显的优势,其临床疗效明显高于对照组患者,数据差异具有统计学意义(P<0.05)。结论比索洛尔治疗慢性心力衰竭患者的疗效显著,值得推广。
Objective To observe the efficacy of 100 cases of bisoprolol in patients with chronic heart failure. Methods A total of 200 patients with chronic heart failure admitted to our hospital from April 2014 to March 2016 were selected as the study subjects and divided into two different groups according to their clinical treatment plan Do not, respectively, defined as the study group and the control group, the average of each group of patients were 100 cases, the control group to take the usual way of treatment, the study group was treated with bisoprolol for patients, contrast and analysis of two A group of clinical efficacy. The results showed that the total effective rate of the study group patients was significantly higher than that of the control group, and the clinical efficacy was significantly higher than that of the control group. The difference was statistically significant (P <0.05). Conclusion Bisoprolol in patients with chronic heart failure has a significant effect and is worth promoting.